About
About Shandong Shanda Wit Science and Technology Co., Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granules, compound calcium carbonate, vitamin AD drops, iprastat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salts, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules. In addition, it offers information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, communication products, and industrial automation control products; and crystal products. The company is also involved in research, development, production, and sales of children's medicines and health products, as well as leasing and property management services. Shandong Wit Dyne Health Co.,Ltd. was founded in 1993 and is based in Jinan, China.
Visit company website
5 years, 4 months ago
Shandong Shanda Wit Science and Technology Co., Ltd is currently in a long term uptrend where the price is trading 10.4% above its 200 day moving average.
From a valuation standpoint, the stock is 68.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Shandong Shanda Wit Science and Technology Co., Ltd's total revenue sank by 6.3% to $454M since the same quarter in the previous year.
Its net income has increased by 27.6% to $63M since the same quarter in the previous year.
Finally, its free cash flow grew by 65.9% to $175M since the same quarter in the previous year.
Based on the above factors, Shandong Shanda Wit Science and Technology Co., Ltd gets an overall score of 4/5.